Intestinal tract slow-release bovine colostrum and sea cucumber peptide chewable tablet and preparation method thereof

A technology of sea cucumber peptides and chewable tablets, which is applied in the intestinal slow-release bovine colostrum sea cucumber peptide chewable tablets and its preparation field, can solve the problems of no specific treatment methods, etc., and achieve the effect of improving taste and enhancing peristalsis

Active Publication Date: 2020-10-27
SHANGHAI JIAO TONG UNIV +1
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Type 2 diabetes is a difficult chronic disease, and there is no specific treatment at present, and the general onset requires life-long medication
However, the prior art lacks chewable tablets that can effectively repair cells after oxidative stress caused by type 2 diabetes or cardiovascular and cerebrovascular diseases, and chewable tablets that can slowly release peptide compositions with therapeutic and nutritional effects in the intestinal tract

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Intestinal tract slow-release bovine colostrum and sea cucumber peptide chewable tablet and preparation method thereof
  • Intestinal tract slow-release bovine colostrum and sea cucumber peptide chewable tablet and preparation method thereof
  • Intestinal tract slow-release bovine colostrum and sea cucumber peptide chewable tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0077] This embodiment provides a chewable tablet of bovine colostrum sea cucumber peptide for intestinal slow-release, and each 1g chewable tablet includes the following ingredients:

[0078] Casein phosphopeptide 1mg;

[0079] Sea cucumber peptide 50mg;

[0080] Bovine colostrum powder 5mg;

[0081] Soy Peptide 70mg;

[0082] Whey Protein Concentrate 114mg;

[0083] Lutein ester 1mg;

[0084] Vitamin C 1mg;

[0085] Fruit and vegetable powder 10mg;

[0086] Resistant Dextrin 1mg;

[0087] Lactose 4mg;

[0088] Erythritol 0.5mg;

[0089] Sorbitol 15mg;

[0090] DL-malic acid 1mg;

[0091]Xylooligosaccharide 1mg;

[0092] Magnesium stearate 0.5mg;

[0093] Targeted sustained-release biocompatible microcapsules 20mg;

[0094] Among them, targeted slow-release biocompatible microcapsules, by weight components, include the following components: 20 parts of polycarbonate film with a pore size of 200 nm and a thickness of 10 mm; 15 parts of bovine serum albumin freeze-...

Embodiment 2

[0123] This embodiment provides a chewable tablet of bovine colostrum sea cucumber peptide for intestinal slow-release, and each 1g chewable tablet includes the following ingredients:

[0124] Casein phosphopeptide 15mg;

[0125] Sea cucumber peptide 1mg;

[0126] Bovine colostrum powder 50mg;

[0127] Soy Peptide 70mg;

[0128] Whey Protein Concentrate 4mg;

[0129] Lutein Esters 40mg;

[0130] Vitamin C 30mg;

[0131] Fruit and vegetable powder 100mg;

[0132] Resistant dextrin 5mg;

[0133] Lactose 1mg;

[0134] Erythritol 10mg;

[0135] Sorbitol 0.5mg;

[0136] DL-malic acid 0.05mg;

[0137] Xylooligosaccharide 0.6mg;

[0138] Magnesium stearate 1mg;

[0139] Targeted sustained-release biocompatible microcapsules 30mg;

[0140] Among them, targeted slow-release biocompatible microcapsules, by weight components, include the following components: 30 parts of polycarbonate film with a pore size of 300 nm and a thickness of 12 mm; 10 parts of bovine serum albumin ...

Embodiment 3

[0168] This embodiment provides a chewable tablet of bovine colostrum sea cucumber peptide for intestinal slow-release, and each 1g chewable tablet includes the following ingredients:

[0169] Casein phosphopeptide 8mg;

[0170] Sea cucumber peptide 25mg;

[0171] Bovine colostrum powder 27.5mg;

[0172] Soy Peptide 37.5mg;

[0173] Whey Protein Concentrate 59mg;

[0174] Lutein Esters 20.5mg;

[0175] Vitamin C 15mg;

[0176] Fruit and vegetable powder 55mg;

[0177] Resistant dextrin 3mg;

[0178] Lactose 2.5mg;

[0179] Erythritol 5.25mg;

[0180] Sorbitol 7.75mg;

[0181] DL-malic acid 0.5mg;

[0182] Xylooligosaccharide 0.8mg;

[0183] Magnesium stearate 0.75mg;

[0184] Targeted sustained-release biocompatible microcapsules 15mg;

[0185] Among them, targeted slow-release biocompatible microcapsules, by weight components, include the following components: 25 parts of polycarbonate film with a pore size of 250 nm and a thickness of 11 mm; 12.5 parts of bovine...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
thicknessaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention provides an intestinal tract slow-release bovine colostrum and sea cucumber peptide chewable tablet and a preparation method thereof. The chewable tablet comprises the following components: casein phosphopeptide, sea cucumber peptide, bovine colostrum powder, soybean peptide, concentrated whey protein, lutein ester, vitamin C, fruit and vegetable powder, resistant dextrin, lactose, erythritol, sorbitol, DL-malic acid, xylooligosaccharide and magnesium stearate; and the chewable tablet also comprises a targeted slow-release biocompatible microcapsule which comprises a polycarbonate film, bovine serum albumin freeze-dried powder, amino acid, chitosan oligosaccharide, lecithin and poly(2-ethyl-2-oxazoline) grafted glucan nanoparticles. The intestinal tract slow-release bovine colostrum and sea cucumber peptide chewable tablet prepared by using the preparation method and the components provided by the invention can release active peptides with quality and nutrition effects inintestinal tracts, and can penetrate through a blood brain barrier to act on brain cells to repair cardiovascular and cerebrovascular diseases and injuries after oxidative stress; and the bovine colostrum powder and the concentrated whey protein are digested in the stomach in an auxiliary manner, so the human immunity is enhanced.

Description

technical field [0001] The invention belongs to the technical field of composite biology, and in particular relates to a slow-release bovine colostrum sea cucumber peptide chewable tablet and a preparation method thereof. Background technique [0002] Type 2 diabetes is a difficult chronic disease, and there is no specific treatment at present, and the general onset requires life-long medication. Type 2 diabetes may lead to various complications, such as neurological, cardiovascular and cerebrovascular complications, and even death in severe cases. And "peptide" is a substance between protein and amino acid. It is a compound connected by two or more amino acids with peptide bonds. It is the core substance of cells and plays an important physiological role in the human body. Physiological function. Various cell functions and all life behaviors in the human body, such as growth, development, reproduction, metabolism, operation, etc., must be realized through peptides. Peptid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/17A61K9/22A61K9/38A61K47/36A61K47/34A61K47/42A61K47/18A61K47/24A61K47/20A61P37/04A61P3/10A61P9/12A61P25/20A61P39/02C08B37/02C12P21/06C07K1/14C07K1/34A61K38/01A61K35/20A61K38/02A61K31/23A61K31/375A61K31/718A61K31/7016A61K31/047A61K31/194A61K31/702A61K36/81
CPCA61K9/0056A61K9/2013A61K9/2031A61K9/205A61K9/2095A61K9/282A61K9/286A61K9/2873A61K9/2893A61K31/047A61K31/194A61K31/23A61K31/375A61K31/7016A61K31/702A61K31/718A61K35/20A61K36/07A61K36/185A61K36/23A61K36/42A61K36/534A61K36/73A61K36/81A61K38/012A61K38/02A61K38/1709A61P3/10A61P9/12A61P25/20A61P37/04A61P39/02C07K1/14C07K1/34C08B37/0006C12P21/06A61K2300/00
Inventor 崔立万鹏
Owner SHANGHAI JIAO TONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap